EMS Stocks Face Profitability Litmus Test in 2026, Says JP Morgan
JP Morgan has designated 2026 as a crucial year for India's EMS sector, emphasizing that stock recovery depends on companies demonstrating improved profitability after significant 2025 underperformance. The brokerage maintains overweight ratings on Syrma SGS Technology, Kaynes Technologies, and Dixon Technologies, while the sector's outlook hinges on mobile PLI scheme extension, ISM 2.0 rollout, and India-US trade deal progress.

*this image is generated using AI for illustrative purposes only.
JP Morgan has identified 2026 as a decisive year for India's electronics manufacturing services ( ems ) sector, warning that stocks in this space face a critical "litmus test" following their sharp underperformance throughout 2025. The global brokerage emphasized that any sustained recovery in these shares will now depend entirely on companies' ability to revive their profitability metrics.
Profitability Key to Recovery
According to JP Morgan's analysis, the sector appears to have already priced in most negative factors, creating a foundation for potential recovery. However, the brokerage stressed that companies must now deliver tangible improvements in their financial performance to restore investor confidence.
"Stocks seem to be pricing in most of the negatives and hence for a rally from here on, companies will have to showcase revenue, margin and cash flow numbers for investor confidence to come back," JP Morgan stated in its note to clients.
Stock Performance and Ratings
The EMS sector witnessed significant volatility in 2025, with most stocks experiencing substantial declines. JP Morgan's current positioning across the sector reflects this mixed performance landscape:
| Company | 2025 Performance | JP Morgan Rating |
|---|---|---|
| Kaynes Technologies | -47% | Overweight |
| Cyient DLM | -36% | Neutral |
| Dixon Technologies | -29% | Overweight |
| Amber Enterprises | -16% | Neutral |
| Avalon Technologies | +2% | Underweight |
| Syrma SGS Technology | +20% | Overweight |
The brokerage maintains an overweight stance on Syrma SGS Technology, Kaynes Technologies, and Dixon Technologies, despite the challenging performance of some of these stocks. Meanwhile, it holds neutral positions on Amber Enterprises and Cyient DLM, and remains underweight on Avalon Technologies.
Critical Catalysts for 2026
JP Morgan identified three key triggers that will determine the EMS sector's trajectory in 2026:
- Mobile PLI Scheme Extension: The potential continuation of performance-linked incentives for mobile manufacturing
- ISM 2.0 Rollout: The expected launch of India Semiconductor Mission 2.0
- India-US Trade Progress: Developments in bilateral trade negotiations between India and the United States
These factors are expected to significantly influence the sector's growth prospects and investor sentiment moving forward. The brokerage's analysis suggests that successful navigation of these catalysts, combined with improved operational metrics, will be essential for the sector's recovery and long-term growth trajectory.
Historical Stock Returns for EMS
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.12% | -12.51% | -25.34% | -47.36% | -57.98% | +18.79% |


































